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Hepatic fibrosis, a disease with highly complex etiology, is 
caused by inappropriate tissue repair due to the deposition of 
connective tissue, resulting in chronic liver damage. It may be 
caused by alcohol consumption, chronic viral hepatitis, and au- 
toimmune diseases, among others. When there is inappropriate 
fibrosis control, the result can be a progression to cirrhosis [1] 
. When an acute injury affects the liver, parenchymal cells are 
regenerated and this process is associated with the inflammatory 
response and limited deposition of extracellular matrix (ECM). 
However, after chronic damage, the regenerative response fails 
and hepatocytes are replaced by excessive ECM mainly made 
of collagen of types I, III and IV, fibronectin, elastin, laminin 
and proteoglycans (Duval et al., 2014a). The main sources of 
ECM are the hepatic stellate cells (HSCs) [2] , which consti- 
tute around 15% of total liver cells [3] . Discovered in 1876 by 
Kuppfer and located within the perisinusoidal space of Disse, 
the HSCs contain fat globules and are responsible for storing 
approximately 80% of vitamin A [4] [5] [6] . These cells play 
an important role in the fibrogenesis that occurs in chronic le- 
   sions of hepatic tissue [7] . The HSCs activation process, when 
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there is phenotypic change from the quiescent state to an acti- 
vated state, can be divided into initiation, perpetuation and res- 
olution, and is an early event in hepatic fibrogenesis. Several 





Liver fibrosis is a complex disease that is caused by inappropriate tissue repair due to the deposition of connective tissue.  
When a chronic lesion affects the liver, regenerative response fails and hepatocytes are replaced with abundant extracellular 
matrix (ECM). The imbalance between production and degradation of ECM will result in the accumulation of proteins that change 
normal liver architecture, and thus its functionality. The main source of ECM is the activated hepatic stellate cell (HSC). In  
order, to clarify possible therapeutic approaches to the disease, this work aimed to evaluate the possible antifibrotic action       
of Pluchea sagitallis (Lam.) Cabrera on an activated HSC immortalized lineage (GRX). Our results demonstrated that the P. 
sagittalis aqueous extract at 0.039 and 0.078 mg/mL concentrations was able to reduce cell growth and proliferation. Regarding 
to oxidative stress evaluation, there was no statistically significant difference between the treated group and the control. Staining 
with OilRed-O (ORO) showed a statistically significant increase in intracellular lipid content after 5 days of treatment, exerting in 
vitro effect on the GRX phenotypic change of activated towards the quiescent state. These results were confirmed by colorimetric 
quantification of lipid content. Regarding the TGF-β1 and collagen production, there were no statistically significant differences 
observed between the groups. In conclusion, the P. sagittalis aqueous extract reduces the growth and proliferation of GRX cells 
and induces the reversal of activated towards a quiescent phenotype. There was no decrease in cell proliferation either by 
necrosis or by apoptosis via activation of the senescence. Thus, our data suggest that the extract showed an antifibrotic effect, 
possibly by activating phenotype reversal. 
Keywords: hepatic fibrosis; hepatic stellate cell; Pluchea sagitallis 
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boring cells can initiate HSCs activation. The activated stellate 
cells are characterized by increased contractility, retinoid loss, 
chemotaxis, proliferation, ECM degradation capacity and secre- 
tion of pro-inflammatory cytokines. TGF-β1 produced by liver 
cells represents a potent fibrogenic signal, since it increases the 
production of type I collagen and other matrix constituents, such 
as fibronectin and proteoglycans. Remarkably, this new ECM 
configuration induces a new fibrogenic stimulus that is responsi- 
ble for exacerbating fibrosis (Duval et al., 2014a). The GRX cell 
line, which represents the activated HSC phenotype, has been 
used as an important tool for the study of the physiology of HSC 
and liver fibrosis [8] [9] . The Pluchea sagitallis (Lam.) Cabr- 
era, which belongs to the Asteraceae family, is a native plant of 
South America, popularly known as “quitoco”, “madre cravo” 
or “tabacarana” [10] . Important properties associated with the 
Pluchea gender, have been described including antioxidant activ- 
ity, and anti-inflammatory and anti-ulcerogenic potential. Phy- 
tochemical studies with P. sagitallis identified several bioactive 
compounds, including flavonoids, phenols, terpenes, tannins, al- 
kaloids and saponins [11] [12] [13] . Regarding to the anti- 
inflammatory property of P. sagitallis, pharmacological studies 
showed that the aqueous extract has anti-inflammatory activity 
that is correlated with a reduction of free radicals [14] . The 
antifibrotic properties of medicinal plants have been mainly re- 
ported mainly in models of in vitro and in vivo liver fibrosis. 
There are two ways in which these plants, together with their 
bioactive compounds, may act in reducing liver fibrosis: via in- 
hibition of HSC activation and via reduction of ECM deposition 
. The advantages of using medicinal plants as possible antifi- 
brotic agents include high safety, cost-effectiveness and versatil- 
ity . Thus, the Pluchea gender seems to be a promising source of 
material on the research of new therapeutic drugs [15] . 
 
Material  and Methods 
 
Materials 
P. sagitallis leaves were collected from the Protection Center and 
Nature Conservation Pro-Mata, at the town of Sa˜o Francisco de 
Paula, Rio Grande do Sul, Brazil, during December 2014 
 
Preparation of the aqueous extract of Pluchea sagitallis 
Aqueous extracts were prepared with P. sagitallis leaves. The 
aqueous extracts were obtained by adapting the methodology 
used by [16] . Initially, 2 g of in nature plant leaves in a properly 
tagged Becker were selected. After cleaning was performed with 
distilled water, with subsequent drying and, thereafter, 10 mL of 
distilled water were added and then this solution was placed in a 
water bath (80◦C) for 30 min. The aqueous extract was filtered 
and centrifuged at 5000 rpm for 10 min and after was divided 




The murine GRX cell line 16 was obtained from the Rio de 
Janeiro Cell Bank (Federal University, Rio de Janeiro, Brazil). 
The GRX cell line was obtained from liver granuloma in mice 
of C3h line / HeN infected with Schistosoma mansoni cer- 
cariae [17] [18] . Under standard cultivation conditions, GRX 
cells express the myofibroblast phenotype, proliferative and 
ECM producer [19] [20] . Cells were maintained in Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 5% fe- 
tal bovine serum (FBS) (Invitrogen, Carlsbad, CA), 2g/L HEPES 
buffer, 3.7g/L NaHCO3 and 1% penicillin and streptomycin (In- 
vitrogen) and incubated at 37◦C in a humidified atmosphere with 
5% CO2 . 
 
Treatment with Pluchea sagitallis aqueous extract 
The aqueous extract of P. sagitallis was used in concentrations 
of 0.039, 0.078, 0.156, 0.312, 0.625, 1.25 and 2,5 mg/mL. Based 
on previous studies, GRX cells were incubated and the analyses 
were performed after 5 days of treatment. all experiments were 
repeated three times and in triplicates [21] . 
 
Viability and cell growth 
Cellular viability and growth were assessed by Tripan blue dye 
exclusion. The number of cells was determined by the hemo- 
cytometer. GRX cells were seeded into 24-well plates (3 x 103 
cells/well) and treated with P. sagitallis aqueous extract (as de- 
scribed above) for 5 days to evaluate the antifibrotic activity. The 
control group received only DMEM and 5% SFB for 5 days. 
 
Cell toxicity by release of lactate dehydrogenase 
We used the determination of lactate dehydrogenase (LDH) in 
supernatants of cultures as compared to the control group in or- 
der to evaluate the cytotoxicity of P. sagitallis aqueous extract 
in GRX cells. The LDH activity was measured by colorimetric 
assay [22] . Control of cell lysis was checked using 5% Tween. 
 
Oxidative stress assessment 
Oxidative stress was assessed by the concentration of MDA  
(malondialdehyde) in the supernatant of cell cultures by Thio- 
barbituric Acid Reactive Substances (TBARS) assay kit (Cay- 
man Chemical Company). The TBARS is a well-established 
method for screening and monitoring of lipid peroxidation. The 
results are expressed in µM per 1.000 cells. 
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Apoptosis and senescence assay 
The GRX cells apoptosis and senescence was assessed by im- 
munofluorescence microscopy (x200). Cells were stained with 
DAPI (Invitrogen, Inc., Carlsbad, CA, USA) to assess nuclear 
changes or modifications of cells undergoing apoptosis. After 
treatment, the supernatant was removed and cells were washed 
three times with PBS and fixed with 4% paraformaldehyde. 
Next, cells were washed again with PBS, permeabilized with 
0.5% Triton X-100 for 30 min and DAPI was added. After 2 
min the dye was removed, and the last wash was performed with 
PBS. Finally, nuclear morphometric analysis (NMA) was per- 
formed to quantitatively evaluate the proportion of cells in senes- 
cence, apoptosis or nuclear irregularities within this population 
of in vitro cells [23] . DAPI staining reveal that apoptotic cells 
shows nuclei with chromatin condensation and apoptotic bodies. 
 
Detection of lipid droplets by Oil Red-O staining 
Cells were stained with Oil Red-O  (ORO)  (Sigma) [24] on 
day 5 to show cell morphology and lipid accumulation. Af- ter 
fixing cells with 10% formaldehyde, ORO (0.35g in 60% 
isopropanol) was briefly added for 15 min. Intracellular lipid 
droplets were examined using an inverted light microscope 
(BestScope, China). 
 
Quantification of lipid accumulation 
The procedure is also based on ORO staining of intracellular 
lipid droplets (Sigma Chemical Co., St. Louis, Mo). Cells were 
briefly fixed with perchloric acid and incubated with ORO dis- 
solved in propylene glycol (2mg/mL) for 2h. The ORO within 
the lipid droplets was extracted using isopropanol. The ab- 
sorbance was read at 492 nm using an ELISA plate reader. Each 
sample was normalized to 100.000 cells. 
 
TGF- β1 Quantification 
TGF-β1 concentration was measured, in cell supernatant, on day 
5, using a commercially available ELISA kit (R&D Systems, 
Minneapolis, MN). Results were calculated on a standard curve 
concentration and multiplied for the dilution factor. TGF-β1 lev- 
els were expressed as nanograms per milliliter per 1.000 cells. 
 
Measurement of collagen content 
Collagen content in GRX cells was measured using Picro Sirius 
Red on day 5. Picro Sirius Red was added to cell supernatant to 
form a collagen-dye complex. After centrifugation, unbound dye 
was removed and collagen-dye complex dissolved in NaOH. The 
absorbance was measured at 540 nm in an ELISA plate reader. 
Each sample was normalized to 1.000 cells [25] . Results were 
calculated on a standard curve concentration. Collagen levels 




Data are reported as mean ± SD. Each experiment was per- 
formed at least three independent times and in triplicates. Statis- 
tical testing was performed with Prism 5 software. Results were 
analyzed by one-way analysis of variance (ANOVA), followed 
by Tukey’s multiple comparison test. The level of significance 
was set at p <0.05. 
Results 
 
Viability and cell growth 
After 5 days of treatment with P. sagitallis aqueous extract, cell 
viability of GRX lineage was evaluated at 0.039, 0.078, 0.15625, 
0.3125, 0.625, 1.25 and 2.5 mg/mL concentrations on cell via- 
bility of GRX lineage. A significant decrease in cell proliferation 
was observed with increasing concentrations of the aqueous ex- 
tract (Fig. 1). 
 
Cell toxicity by release of lactate dehydrogenase 
In order to evaluate whether the reduction in number of cells 
treated with P. sagitallis aqueous extract was due to cytotoxic- 
ity, the lactate dehydrogenase (LDH) released was quantified in 
the culture medium. Among the concentrations tested, there was 
a statistically significant difference at 1.25 and 2.5mg/mL con- 
centrations compared to the control, indicating cytotoxicity (Fig. 
2). Thus, 0.039 and 0.078 mg/mL concentrations of P. sagitallis 
aqueous extract were selected for this study because lower con- 
centrations had already presented an antiproliferative effect. 
 
Oxidative stress assessment 
Oxidative stress can damage the cell and, consequently, decrease 
cellular proliferation, allowing to evaluate MDA formation by 
MDA by TBARS assay. Our results showed that there was no 
statistically significant difference between the treated groups and 
the control group (Fig. 3). 
 
Apoptosis and senescence assay 
Regarding the evaluation of apoptosis and senescence measured 
by DAPI, there was no statistically significant difference be- 
tween treated groups and the control group Thereby apoptotic 
and senescent cells were not detected in the studied groups (Fig. 
4 A, B, C, D, E). 
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Detection of lipid droplets by Oil Red-O staining and 
quantification of lipid accumulation 
When activated, stellate hepatic cells alter their phenotype and, 
therefore, increase their proliferation rate. In order to verify 
whether antiproliferative mechanism of P. sagitallis aqueous ex- 
tract could be via phenotype regression, we assessed their lipid 
content. Control cells, which did not receive any treatment, had 
preserved their myofibroblastic phenotype (Fig. 5A). However, 
cells that were treated with P. sagitallis aqueous extract at 0.039 
and 0.078 mg/mL concentrations showed a reversal of activated 
to quiescent phenotype (Fig. 5B, C). 
The phenotype reversal was confirmed by colorimetric quan- 
tification of intracellular lipid content. There was a  statistically 
 
significant increase in intracellular lipid content at 0.078 mg/mL 
concentration of P. sagitallis aqueous extract when compared to 
the control (Fig. 6). 
 
TGF-β1 Quantification 
There was no statistically significant difference in the amount of 
TGF-β1 between the treated groups and the control group after 
5 days of treatment (Fig. 7). 
 
Measurement of collagen content 
There was no statistically significant difference in collagen con- 
tent between the treated groups and the control group after 5 











Figure 1 Effect ofPluchea sagitallis in GRX cells growth, assessed by direct counting onNeubaue´r s Chamber. Cells were treated with P.sagitallis 
aqueous extract for 5 days. Data represent the mean ± SD (n=4). Results are expressed as cellnumber per well. ***p<0.01 compared 
Figure 2 Effect of PlucheaSagitallis in lactate dehydrogenase (LDH) release on cell supernatant after 5 days. Data represent the mean ± SD 
(n=4). Results are expressed aspercentage of LDH. ** p<0.01 and ***p< 0,001 compared to control. 
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Figure 3 TBARS levels in GRX cell line after 5 days oftreatment. Datarepresent the mean± SD (n= 4). TBARS levels were the expressedper 





















Figure 4 DAPI Staining to assess nuclearchanges or modifications ofcells undergoing apoptosis and senescence. A. Control; B. 0.039; C.0.078 








Figure 5 OilRed-O (ORO) staining and lipid quantitation of GRX cells at day 5.(A) Control cells; (B, C) cells treated with Pluchea sagitallisaqueous 
extract at 0.039 and 0.078 mg/mL,respectively. Bar length = 20 µm. The arrows show the lipid droplets in cellstreated with Pluchea sagitallis and 
absent in the control group. 
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Liver fibrosis is a multifactorial process feature by an imbalance 
of components of ECM synthesis and degradation, resulting in 
proteins accumulation that change normal liver architecture and, 
consequently, their functionality. GRX cells represent an inter- 
esting study of liver fibrosis model because in basal culture con- 
ditions exhibit the myofibroblastic fenotype [26] . This study 
demonstrated that P. sagitallis aqueous extract decreased GRX 
cells proliferation rate at the tested concentrations. Initially, we 
evaluated the possible cytotoxic action of the aqueous extract. 
We found that at 1.25 and 2.5 mg/mL concentrations the ex- 
tract was toxic to cells, as it caused cell necrosis. This was ev- 
idenced by the significant increase of LDH in the cell culture 
supernatant. Based on these results, we decided to investigate 
the cellular mechanism involved in the antiproliferative effect of 
the P. sagitallis aqueous extract at 0.039 and 0.078 mg/mL con- 
centrations. Oxidative stress is present in many liver diseases. 
This process happens due to an imbalance between oxidants and 












Figure 6 Specific lipid content expressedspectrophotometrically as the ratio of absorbance value obtained for ORO andthe cell number. Results 
are expressed as mean ± SD. ** **p<0.01, comparedto control. 
Figure 7 ELISA assay of TGF-β1 in cell supernatantof 5 days treatment. Datarepresent the mean ± SD (n=4). TGF-β1 levels are expressed as 
nanogramsper milliliter per 1000 cells. 
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This fact leads to the oxidation of biomolecules with consequent 
loss of biological functions and homeostatic imbalances, ending 
in a powerful oxidative damage to cells and tissues The hep- 
atic damage can lead to an inflammatory condition which acti- 
vates hepatic stellate cells, initiating the fibrotic process [27] . 
Our results showed no statistically significant differences in ox- 
idative stress among treated and control groups, demonstrating 
that the antiproliferative effect did not occur via oxidative stress. 
Apoptosis plays an important role in the homeostasis of the liver 
cells, considering that many diseases that affect their cells are 
associated with increased apoptosis in hepatocytes, in order to 
protect against organ inflammation. Therefore, programmed cell 
death causes the hepatocytes die without causing a potentially 
damaging inflammatory response (Neuman, 2001). Our results 
demonstrated that the aqueous extract treatment did not increase 
the cell death by apoptosis, as well as not changing the senes- 
cent cells number, which could decrease cell proliferation by 
disrupting the cell cycle. The GRX cell proliferation is related to 
the myofibroblastic phenotype. Therefore, we histologically an- 
alyzed the possible reversal of the phenotype and evaluated the 
intracellular lipid content. Our results showed an accumulation 
in intracellular lipid content as evidenced by ORO staining and 
confirmed by intracellular lipids quantification. For this reason, 
the P. sagitallis aqueous extract acts as a potent inducer of qui- 
escent phenotype. This effect may explain the antiproliferative 
action of the plant. TGF-β1 is the major pro-fibrotic cytokine  
in chronic hepatic injury. This mediator activates the HSCs, re- 
sulting in increased cell proliferation and ECM deposition [28] . 
Increased TGF-β1 levels represent a potent fibrogenic signal and 
its increase is associated with increased collagen production [29] 
.Ours results showed concentrations of TGF-β1, -***when an- 
alyzed in supernatant GRX cell line, no statistically significant 
difference between the groups treated with P. sagitallis aqueous 
extract and the control group. The same occurred when we as- 
sessed the collagen concentration. Although these results show 
no differences between the groups, there was consistency, since 
TGF-β1 and collagen are related to each other. According to 
Ye & Dan (2010), the collagen expression and production are 
decreased when TGF-β1 synthesis decreases and, consequently, 
so does the fibrotic process. Our results showed no significant 
decrease in these parameters, probably because the incubation 
time of the cells and the studied doses, despite decreasing cell 
proliferation and GRX cells phenotype reversion were not suffi- 
cient to decrease TGF-β1 and collagen synthesis. In conclusion, 
this study demonstrated for the first time a possible antiprolifer- 
ative effect of P. sagitallis in an in vitro model of liver fibrosis. 
The results showed that the plant aqueous extract 0.078 mg/mL 
concentrations, was able to induce reversion from quiescent to 
activated phenotype in GRX cell line. Based on our findings, this 
study suggests a possible role for the P. sagitallis aqueous extract 
in liver fibrosis treatment. The findings highlight the importance 
of further research in this area towards a more efficient and effec- 
tive treatment. A better understanding of fibrogenesis inhibition 
and HSCs pathways activation and deactivation are still chal- 
lenges to be unraveled, not only have a better understanding of 
disease pathogenesis, but also to validate the therapeutic use of 
medicinal plants in liver fibrosis. 
Figure 8 Total collagen content in cell supernatant of 5days treatment. Datarepresent the mean ± SD (n=4). Results are expressed as 
microgramsper milliliter / 1000 cells 
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